Clopidogrel reduces obliterative airways disease after trachea transplantation in mice April 21, 2011
CH-5424802 shows promise in ALK-positive tumors and advances in phase I/II trial in NSCLC April 21, 2011
Presidio Pharma updates progress of HCV NS5A inhibitors PPI-461, PPI-437, PPI-668 and PPI-833 April 21, 2011
Expression of transient receptor potential TRPM7 channel predicts poor survival in NPC April 21, 2011
PET tracer BAY-86-4367 is safe in subjects with primary prostate cancer in phase I study April 21, 2011
RSS